Vairetti M, Ferrigno A, Rizzo V, Ambrosi G, Bianchi A, Richelmi P, Blandini F, Armentero MT. Impaired hepatic function and central dopaminergic denervation in a rodent model of Parkinson’s disease: A self-perpetuating crosstalk? Biochim Biophys Acta 2012; 1822(2):176-84
Melcangi RC, Caruso D, Levandis G, Abbiati F, Armentero MT, Blandini F. Modifications of Neuroactive Steroid Levels in an Experimental Model of Nigrostriatal Degeneration: Potential Relevance to the Pathophysiology of Parkinson’s Disease. J Mol Neurosci 2012; 46(1):177-83
Tiloca C, Ratti A, Pensato V, Castucci A, Sorarù G, Del Bo R, Corrado L, Cereda C, D’Ascenzo C, Comi GP, Mazzini L, Castellotti B, Ticozzi N, Gellera C, Silani V, Mutational analysis of VCP gene in familial amyotrophic lateral sclerosis. Neurobiol Aging 2012; 33(3):630.e1-2
Tassorelli C, Furnari A, Buscone S, Alfonsi E, Pacchetti C, Zangaglia R, Pichiecchio A, Bastianello S, Lozza A, Allena M, Bolla M, Sandrini G, Nappi G, Martignoni E. Pisa syndrome in Parkinson’s disease: Clinical, electromyographic, and radiological characterization. Mov Disord 2012; 27(2):227-35
Milani P, Gagliardi S, Bongioanni P, Grieco GS, Dezza M, Bianchi M, Cova E, Ceroni M, Cereda C. Effect of the 50bp deletion polymorphism in the SOD1 promoter on SOD1 mRNA levels in Italian ALS patients. J Neurol Sci 2012; 313(1-2):75-8
Cova L, Bossolasco P, Armentero MT, Diana V, Zennaro E, Mellone M, Calzarossa C, Cerri S, Lambertenghi Deliliers G, Polli E, Blandini F, Silani V. Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: implications for reparative therapy in Parkinson’s disease. Apoptosis 2012; 17(3):289-304
Blandini F, Armentero MT. New pharmacological avenues for the treatment of l-DOPA-induced dyskinesias in Parkinson’s disease: targeting glutamate and adenosine receptors. Expert Opin Investig Drugs 2012; 21(2):153-68
Bossolasco P, Cova L, Levandis G, Diana V, Cerri S, Lambertenghi Deliliers G, Polli E, Silani V, Blandini F, Armentero MT. Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson’s disease. Int J Nanomedicine 2012; 7: 435 – 47
Blandini F, Armentero MT. Animal models of Parkinson’s disease. FEBS J 2012; 279(7):1156-66
Zucchella C, Bartolo M, Pasotti C, Chiapella L, Sinforiani E. Caregiver Burden and Coping in Early-stage Alzheimer Disease. Alzheimer Dis Assoc Disord 2012; 26(1): 55-60
Gagliardi S, Ghirmai S, Abel KJ, Lanier M, Gardai SJ, Lee C, Cashman JR. Evaluation in vitro of synthetic curcumins as agents promoting monocytic gene expression related to -amyloid clearance. Chem Res Toxicol 2012; 25(1):101-12
Guareschi S, Cova E, Cereda C, Ceroni M, Donetti E, Bosco DA, Trotti D, Pasinelli P. An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc Natl Acad Sci U S A 2012; 109(13):5074-9
Cashman JR, Gagliardi S, Lanier M, Ghirmai S, Abel KJ, Fiala M. Curcumins Promote Monocytic Gene Expression Related to -Amyloid and Superoxide Dismutase Clearance. Neurodegener Dis 2012; 10(1-4):274-6
Gagliardi S, Davin A, Ricca I, Grieco GS, Zangaglia R, Pierelli F, Ghiroldi A, Pacchetti C, Casali C, Cereda C. A new GLUT-1 mutation in a family with glucose transporter 1 deficiency syndrome. Mov Disord 2012; 27(6):804-5
Palesi F, Vitali P, Chiarati P, Castellazzi G, Caverzasi E, Pichiecchio A, Colli-Tibaldi E, D’Amore F, D’Errico I, Sinforiani E, Bastianello S. DTI and MR Volumetry of Hippocampus-PC/PCC Circuit: In Search of Early Micro- and Macrostructural Signs of Alzheimers’s Disease. Neurol Res Int 2012; 2012(–): 517876
Morelli M, Blandini F, Simola N, Hauser RA. A(2A) Receptor Antagonism and Dyskinesia in Parkinson’s Disease. Parkinsons Dis 2012; 2012(–):489853
Gagliardi S, Milani P, Sardone V, Pansarasa O, Cereda C. From Transcriptome to Noncoding RNAs: Implications in ALS Mechanism. Neurol Res Int 2012; 2012(–):278725
Colucci M, Cervio M, Faniglione M, De Angelis S, Pajoro M, Levandis G, Tassorelli C, Blandini F, Feletti F, De Giorgio R, Dellabianca A, Tonini S, Tonini M . Intestinal dysmotility and enteric neurochemical changes in a Parkinson’s disease rat model. Auton Neurosci 2012; 169(2):77-86
Pisani V, Stefani A, Pierantozzi M, Natoli S, Stanzione P, Franciotta D, Pisani A. Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson’s disease. J Neuroinflammation 2012; 9(1):188
Ratti A, Corrado L, Castellotti B, Del Bo R, Fogh I, Cereda C, Tiloca C, D’Ascenzo C, Bagarotti A, Pensato V, Ranieri M, Gagliardi S, Calini D, Mazzini L, Taroni F, Corti S, Ceroni M, Oggioni GD, Lin K, Powell JF, Sorarù G, Ticozzi N, Comi GP, D’Alfonso S, Gellera C, Silani V.C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol Aging 2012; 33(10):2528.e7-2528.e14
Giannicola G, Rosa M, Servello D, Menghetti C, Carrabba G, Pacchetti C, Zangaglia R, Cogiamanian F, Scelzo E, Marceglia S, Rossi L, Priori A. Subthalamic Local Field Potentials After Seven-Years Deep Brain Stimulation in Parkinson’s Disease. Exp Neurol 2012; 237(2):312-317
Mauri M, Sinforiani E, Zucchella C, Cuzzoni MG, Bono G. Progression to dementia in a population with amnestic mild cognitive impairment: clinical variables associated with conversion. Funct Neurol 2012; 27(1):49-54
Zangaglia R, Pasotti C, Mancini F, Servello D, Sinforiani E, Pacchetti C. Deep brain stimulation and cognition in Parkinson’s disease: An eight-year follow-up study. Mov Disord 2012; 27(9):1192-4
Tinazzi M, Cipriani A, Matinella A, Cannas A, Solla P, Nicoletti A, Zappia M, Morgante L, Morgante F, Pacchetti C, Sciarretta M, Dallocchio C, Rossi S, Malentacchi M, Ceravolo R, Frosini D, Sestini S, Bovi T, Barbui C. FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. Schizophr Res 2012; 139(1-3):40-5
Sinforiani E, Pasotti C, Chiapella L, Malinverni P, Zucchella C. Memantine in Alzheimer’s disease: experience in an Alzheimer’s disease assessment unit. Aging Clin Exp Res 2012; 24(2):193-6
Ferrari M, Martignoni E, Blandini F, Riboldazzi G, Bono G, Marino F, Cosentino M. Association of UDP-glucuronosyl transferase 1A9 polymorphisms with adverse reactions to catechol-O-methyltransferase inhibitors in Parkinson’s disease patients. Eur J Clin Pharmacol 2012; 68 (11): 1493-9
Sinforiani E, Pasotti C, Chiapella L, Picascia M, Zucchella C. Clinical characteristics of population referred to an Italian center for dementia. Aging Clin Exp Res. 2012; 24:104-5
Zucchella C, Sinforiani E, Citterio A, Giarracca V, Bono G, Mauri M. Reproductive life events and Alzheimer’s disease in Italian women: a retrospective study. Neuropsychiatr Dis Treat 2012; 8(–):555-60
Nisticò R, Cavallucci V, Piccinin S, Macrì S, Pignatelli M, Mehdawy B, Blandini F, Laviola G, Lauro D, Mercuri NB, D’Amelio M . Insulin Receptor -Subunit Haploinsufficiency Impairs Hippocampal Late-Phase LTP and Recognition Memory. Neuromolecular Med 2012; 14(4):262-9
Lanni C, Garbin G, Lisa A, Biundo F, Ranzenigo A, Sinforiani E, Cuzzoni G, Govoni S, Ranzani GN, Racchi M. Influence of COMT Val158Met Polymorphism on Alzheimer’s Disease and Mild Cognitive Impairment in Italian Patients. J Alzheimers Dis 2012; 32(4):919-26
Stanga S, Lanni C, Sinforiani E, Mazzini G, Racchi M. Searching for Predictive Blood Biomarkers: Misfolded p53 in Mild Cognitive Impairment. Curr Alzheimer Res 2012; 9(10):1191-7
Cosentino M, Blandini F, Armentero MT, Martignoni ES, Nappi G, Lecchini S, Marino F. The neurotoxins rotenone, paraquat and manganese exert different effects on human isolated Lymphocites. J Pharmaceutical Sciences and Research 2012; Vol.4(2): 1697-702
Sassi M, Zekaj E, Grotta A, Pollini A, Pellanda A, Borroni M, Pacchetti C, Menghetti C, Porta M, Servello D. Safety in the Use of Dexmedetomidine (Precedex) for Deep Brain Stimulation Surgery: Our Experience in 23 Randomized Patients. Neuromodulation 2012